Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Emerging Role of Targeted Therapy in Metastatic Pancreatic Adenocarcinoma
Brandon M. Huffman, Haley Ellis, Alexander C. Jordan, et al.
Cancers (2022) Vol. 14, Iss. 24, pp. 6223-6223
Open Access | Times Cited: 16

Showing 16 citing articles:

The Potent G-Quadruplex-Binding Compound QN-302 Downregulates S100P Gene Expression in Cells and in an In Vivo Model of Pancreatic Cancer
Ahmed A. Ahmed, William Greenhalf, Daniel H. Palmer, et al.
Molecules (2023) Vol. 28, Iss. 6, pp. 2452-2452
Open Access | Times Cited: 17
Methylthioadenosine Phosphorylase Genomic Loss in Advanced Gastrointestinal Cancers
Natalie Ngoi, Tin‐Yun Tang, Cátia F. Gaspar, et al.
The Oncologist (2024) Vol. 29, Iss. 6, pp. 493-503
Open Access | Times Cited: 5
Current status of cancer genome medicine for pancreatic ductal adenocarcinoma
Toshifumi Doi, Takeshi Ishikawa, Michihisa Moriguchi, et al.
Japanese Journal of Clinical Oncology (2025)
Closed Access
Targeting PIKfyve-driven lipid homeostasis as a metabolic vulnerability in pancreatic cancer
Caleb Cheng, Jing Hu, Rahul Mannan, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 3
BI-2865, a pan-KRAS inhibitor, reverses the P-glycoprotein induced multidrug resistance in vitro and in vivo
Qihong Yang, Kenneth K.W. To, Guilin Hu, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 2
Analysis on the pathogenesis and treatment progress of NRG1 fusion-positive non-small cell lung cancer
Hongyan Li, Lina Xu, Hongshun Cao, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 2
A Phase I Expansion Cohort Study Evaluating the Safety and Efficacy of the CHK1 Inhibitor LY2880070 with Low-dose Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma
Brandon M. Huffman, Hanrong Feng, Kalindi Parmar, et al.
Clinical Cancer Research (2023) Vol. 29, Iss. 24, pp. 5047-5056
Open Access | Times Cited: 4
Fatty acids abrogate the growth-suppressive effects induced by inhibition of cholesterol flux in pancreatic cancer cells
Yuchuan Li, Manoj Amrutkar, Anette Vefferstad Finstadsveen, et al.
Cancer Cell International (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 4
Trends and hotspots of prognostic factors for pancreatic ductal adenocarcinoma from 2013 to 2022
Jieyu Peng, Muhan Lv, Yan Peng, et al.
HepatoBiliary Surgery and Nutrition (2024) Vol. 13, Iss. 2, pp. 370-373
Open Access | Times Cited: 1
Triple Blockade of Oncogenic RAS Signaling Using KRAS and MEK Inhibitors in Combination with Irradiation in Pancreatic Cancer
XUAN WANG, Judith Breuer, Stephan Garbe, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 6249-6249
Open Access | Times Cited: 1
Novel Pt (II) Complexes With Anticancer Activity Against Pancreatic Ductal Adenocarcinoma Cells
Erika Stefàno, Gianluca Rovito, Luca Giulio Cossa, et al.
Bioinorganic Chemistry and Applications (2024) Vol. 2024, Iss. 1
Open Access
Investigation of an anticancer activity of combination of interferon-alpha and gemcitabine on pancreatic cancer cells
Orkhan Isayev, Darina V. Sokolova, N. Yu. Anisimova, et al.
Journal of Cancer Research and Therapeutics (2024) Vol. 20, Iss. 5, pp. 1494-1498
Open Access
Big insights from small samples: uncovering the potential of EUS-guided FNAs in pancreatic cancer through predictive genomics and transcriptomics
Melissa Zhao, Anirban Maitra, Jonathan A. Nowak
EBioMedicine (2024) Vol. 109, pp. 105380-105380
Open Access
Pancreatic Cancer-Secreted Proteins: Targeting Their Functions in Tumor Microenvironment
Anna Lisa Cammarota, Antonia Falco, Anna Basile, et al.
Cancers (2023) Vol. 15, Iss. 19, pp. 4825-4825
Open Access | Times Cited: 1
Identification of an optimal mutant allele frequency to detect activating KRAS, NRAS, and BRAF mutations in a commercial cell-free DNA next-generation sequencing assay in colorectal and pancreatic adenocarcinomas
Bennett Adam Caughey, Kumiko Umemoto, Michelle Green, et al.
Journal of Gastrointestinal Oncology (2023) Vol. 14, Iss. 05, pp. 2083-2096
Open Access | Times Cited: 1
Fatty acids abrogate the growth-suppressive effects induced by inhibition of cholesterol flux in pancreatic cancer cells
Yuchuan Li, Manoj Amrutkar, Anette Vefferstad Finstadsveen, et al.
Research Square (Research Square) (2023)
Open Access
Page 1

Scroll to top